67 results
PRE 14A
SAGE
Sage Therapeutics Inc
8 Dec 23
Preliminary proxy
8:30am
package and a meaningful part of our pay-for-performance philosophy.
As discussed in more detail below, none of the new stock options issued under
8-K
EX-99.1
y6adx0y gc99t
24 Feb 22
Sage Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Highlights Pipeline and Business Progress
6:45am
8-K
EX-99.1
xe6h3ovn4nb2n
10 Jan 22
Regulation FD Disclosure
7:31am
8-K
EX-99.1
5nq1px0bz3yjqh7b
2 Nov 21
Sage Therapeutics Announces Third Quarter 2021 Financial Results and Highlights Pipeline and Business Progress
7:30am